NIAID conducts and supports basic research to better understand viruses, bacteria, and other infectious agents that cause diseases of public health concern. This research provides the foundation for developing medical products and strategies to diagnose, treat, and prevent a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism.
Sequential Immunization with VSV-Based Lassa and Ebola Vaccines Does Not Diminish Protection in Monkeys, NIAID Study Finds—Nov. 14, 2014
NIH to Launch Human Safety Study of Ebola Vaccine Candidate—Aug. 28, 2014
Media Availability: Ebola Outbreak Highlights Global Disparities in Healthcare Resources—Aug. 13, 2014
Media Availability: NIH Scientists Describe How Anthrax Toxins Cause Illness, Death—Aug. 28, 2013
All Biodefense and Emerging Infectious Diseases News and Events
Last Updated November 14, 2014